Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese women

Atherosclerosis

Volumn 172, Issue 1, 2004, Pages 175-180

  Porreca, Ettore ^a   Di Febbo, Concetta ^a   Fusco, Luigia ^a   Moretta, Valeria ^a   Di Nisio, Marcello ^a   Cuccurullo, Franco ^a  

^a Centro Servizi Biomedici   (Italy)

Author keywords

Leptin; Obesity; Soluble thrombomodulin; sVCAM 1

Indexed keywords

LEPTIN; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE 1;

ABDOMEN; ADULT; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BODY WEIGHT; CALORIC RESTRICTION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID SOLUBILITY; MULTIPLE REGRESSION; NORMAL HUMAN; OBESITY; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REDUCTION; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

EID: 0346725006     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.09.022     Document Type: Article

References (31)

1. Mantzoros C.S. The role of leptin in human obesity and disease: a review of current evidence. Ann. Intern. Med. 130:1999;671-680.
2. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R.et al. Serum immunoreactive-leptin concentrations in normal-weight and obese human. N. Engl. J. Med. 334:1996;292-295.
3. Wallace A.M., McMahon A.D., Packard C.J., Kelly A., Shepherd J., Gaw A. et al. Plasma leptin and the risk of cardiovascular disease in West of Scotland Coronary Prevention Study (WOSCOPS). Circulation. 104:2001;3052-3056.
4. Konstantinides S., Schafer K., Koschnick S., Loskutoff D.J. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J. Clin. Invest. 108:2001;1533-1540.
5. Bondary P.F., Westrick R.J., Wickenheiser K.J., Shen Y., Eitzman D.T. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA. 287:2002;1706-1709.
6. Gainsford T., Willson T.A., Metcalf D., Handman E., McFarlane C., Ng A. et al. Leptin can induce proliferation, differentiation, and functional activation of hematopoietic cells. Proc. Natl. Acad. Sci. U.S.A. 93:1996;14564-14568.
7. Bouloumé A., Marumo T., Lafontan M., Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J. 13:1999;1231-1238.
8. Ross. Atherosclerosis. An inflammatory disease. N Engl J Med 1999;340:115-6.
9. Ferri C., Desideri G., Valenti M., Bellini C., Pasin M., Santucci A.et al. Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension. 34:1999;568-573.
10. Yudkin J.S., Stehouwer C.D.A., Emeis J.J., Coppack S.W. C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue. Arterioscler. Thromb. Vasc. Biol. 19:1999;972-978.
11. Ziccardi P., Nappo F., Giugliano G., Esposito K., Marfella R., Cioffi M.et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 105:2002;804-809.
12. Esmon CT. Protein C, protein S, and thrombomodulin. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, editors. Hemostasis and thrombosis. Basic principles & clinical practice. Lippincott Williams & Wilkins; 2001. p. 335-53.
13. De Caterina R., Basta G., Lazzerini G., Dell'Omo G., Petrucci R., Morale M.et al. Soluble vascular adhesion molecule-1 as a bioumoral correlate of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17:1997;2646-2654.
14. Nawroth P.K., Conradt C., Nordt T., Wiess T., Boehme M., Wunsch A.et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler. Thromb. Vasc. Biol. 17:1997;505-512.
15. Eckel R.H. Obesity and heart disease. A Statement for Healtcare Professionals from Nutritional Committee, American Heart Association. Circulation. 96:1997;3248-3250.
16. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
17. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419.
18. Eckel R.H., Barouch W.W., Ershow A.G. Report of the National Heart, Lung, and Blood Institute - National Institute of Diabetes and Digestive and Kidney Disease Working Group on pathophysiology of obesity-associated cardiovascular disease. Circulation. 105:2002;2923-2928.
19. Gearing A.J.H., Newman W. Circulating molecules in disease. Immunol. Today. 14:1993;506-512.
20. Otsuki M., Hashimoto K., Morimoto Y., Kishimoto T., Kasayama S. Circulating vascular adhesion molecule-1 in atherosclerotic NIDDM patients. Diabetes. 46:1997;2096-2101.
21. Marfella R., Esposito K., Giunta R., Coppola G., De Angelis L., Farzati B.et al. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation. 101:2000;2247-2251.
22. Hackman A., Abe Y., Insull W., Pownall H., Smith L., Dunn K.et al. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation. 93:1996;1334-1338.
23. Ishii H., Uchiyama H., Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb. Haemost. 65:1991;618-623.
24. Constans J., Blann A.D., Renard M., Guérin V., Conri C. Soluble thrombomodulin in hypercholesterolemic patients. Lancet. 355:2000;145.
25. Makris T. Thrombomodulin levels in patients with arterial hypertension. Am. J. Med. 103:1997;331.
26. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 282:1999;2131-2135.
27. Lemieux I., Pascot A., Prud'homme D., Almeras N., Bogaty P., Nadeau A.et al. Elevated C-reactive protein Another component of the atherothrombotic profile of abdominal obesity. Arterioscler. Thromb. Vasc. Biol. 21:2001;961-967.
28. Hak A.E., Stehouwer C.D.A., Bots M.L., Polderman K.H., Schlkwijk C.G., Westendorp I.C.D.et al. Associacion of C-reactive protein with measure of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-age women. Arterioscler. Thromb. Vasc. Biol. 19:1999;1986-1991.
29. Loffreda S., Yang S.Q., Linz H.Z., Karp C.L., Brengman M.L., Wang D.J.et al. Leptin regulates proinflammatory immune responses. FASEB J. 12:1998;57-65.
30. Grundy S.M. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation. 105:2002;2696-2698.
31. McGill H.C., McMahan C.A., Herderick E.E., Zieske A.W., Malcom G.T., Tracy R.E.et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 105:2002;2712-2718.